Kit for detecting expression level of 17 beta-hydroxysteroid dehydrogenase 7 in human prostate cancer
A technology for hydroxysteroids and prostate cancer, applied in the biological field, can solve problems such as low resolution and inaccurate quantification, achieve high sensitivity, reduce false positive rate, and improve detection sensitivity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0035] Fluorescent quantitative RT-PCR detection of 17β-HSD7 expression in human prostate cancer samples
[0036] 1. Experimental materials
[0037] Trizol reagent was purchased from Invitrogen Company of the United States; MMLV reverse transcriptase, Taq DNA polymerase, and OligodT were purchased from Promega Company of the United States; 7900HT fluorescent quantitative PCR instrument was purchased from ABI Company of the United States.
[0038] 2. Primer and probe design and synthesis:
[0039] 17β-HSD7, GAPDH full-length cDNA sequence as a template, using Primer Express TM 2.0 software analyzes TaqMan primers and probe sites, and selects the best combination.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com